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Primary endemic Cryptococcosis gattii by molecular type VGII 
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In order to study the infectious agents causing human disseminated cryptococcosis in the state of Pará, North 
Brazil, 56 isolates of Cryptococcus spp. (54 isolated from cerebral spinal fluid and two from blood cultures) from 43 
cases diagnosed between 2003-2007 were analysed. The species were determined through morphological and physi-
ological tests and genotypes were determined by URA5-RFLP and PCR-fingerprinting (wild-type phage M13). The 
following species and genotypes were identified: Cryptococcus neoformans VNI (28/56, 50%), Cryptococcus gattii 
VGII (25/56, 44.64%) and C. gattii VGI (3/56, 5.26%). The genotype VNI occurred in 12 out of 14 HIV-positive adults, 
whereas the genotype VGII occurred in 11 out of 21 HIV-negative adults (p < 0.02, OR = 6.6 IC95% 0.98-56.0). All 
patients less than 12 years old were HIV negative and six cases were caused by the VGII genotype, one by the VGI 
and one by VNI. Therefore, endemic primary mycosis in HIV-negative individuals, including an unexpectedly high 
number of children, caused by the VGII genotype deserves further study and suggests the need for surveillance on 
cryptococcal infection in the state of Pará, Eastern Amazon.
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Cryptococcosis is a significant life-threatening fungal 
infection that affects humans and a large variety of ani-
mals. It is caused by two species of Cryptococcus, C. neo-
formans (serotypes A, D and the hybrid AD) and C. gattii 
(serotypes B and C). C. gattii, previously regarded as a 
variety of C. neoformans, is now recognized as a distinct 
species (Kwon-Chung & Varma 2006).
C. neoformans-induced cryptococcosis occurs world-
wide and is an important cause of morbidity and mortali-
ty in immunocompromised individuals, especially AIDS 
patients. Cryptococcosis caused by C. gattii, however, is 
mainly seen in non-immunocompromised patients (La-
zera et al. 2005) and regarding its geographical distribu-
tion, it is considered a tropical pathogen. However, the 
recent description of the Vancouver Island (Canada) out-
break suggests that C. gattii has adapted to more temper-
ate environments (Kidd et al. 2004).
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The infections caused by C. neoformans and C. gattii, 
as well as their corresponding serotypes and molecular 
types, present with different clinical symptoms and have 
a diverse prognosis. Therefore, an understanding of the 
prevailing species and types in specific geographic re-
gions is important. The mycosis caused by C. neoformans 
serotype A is widespread and predominantly infects im-
munocompromised individuals. However, C. neoformans 
serotype D is predominantly found in Europe and mainly 
infects elderly subjects, although it has been rarely detect-
ed in Brazil (Dromer et al. 1996, Nishikawa et al. 2003). 
Cryptococcosis caused by C. gattii (mainly serotype 
B) has been predominantly detected in immunocom-
petent patients and presents as a regressive lung lesion 
which is usually undetected, or as a peripheral lung nod-
ule which has to be differentiated from a malignant tu-
mour. Both species cause a basal meningoencephalitis, 
with or without lung lesions, that usually causes an in-
creased intracranial pressure, cranial nerve damage and 
hydrocephalus. In HIV-negative patients the infection 
may also cause blindness and hearing loss. Cryptococ-
cosis caused by C. gattii typically evolves sub-acutely 
or chronically and is often confused with viral or bacte-
rial meningoencephalitis or other infections, including 
tuberculosis (Lazera et al. 2005, Lin & Heitman 2006). 
C. neoformans serotype A is ubiquitous and has been 
associated with organic material in pigeon habitats, cap-
tive birds in domestic environments, domestic dust and 
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wood decay in hollow trees of different species (Passoni 
et al. 1998, Nishikawa et al. 2003). In Brazil, it is the 
most prevalent serotype in clinical (89%) and environ-
mental isolates (90.2%) in the South, Southeast and Cen-
tral West regions, whereas C. gattii predominates in the 
Northeast region in clinical and environmental isolates 
(64%) (Nishikawa et al. 2003). 
Most clinical isolates are haploid and heterothallic 
but some may be aneuploid or even diploid. The mating 
type of Cryptococcus is determined by a one-locus, two 
allele system (MAT α and MAT a) that produces viable 
progeny in vitro in a 1:1 ratio. Clinical and environmen-
tal isolates are predominantly MAT α, which has been 
suggested to be of higher virulence in animal models 
(Kwon-Chung & Bennett 1992). 
PCR fingerprinting is being used in ongoing global 
surveys to study the epidemiology of cryptococcosis. 
By using primers for the minisatellite-specific core 
sequence of the wild-type phage M13, in combination 
with URA5-RFLP analysis, eight major molecular types 
(VN I-IV for C. neoformans and VG I-IV for C. gattii) 
have been identified (Meyer et al. 2003). The correspond-
ing genotypes of these molecular types were identified 
using amplified fragment length polymorphism PCR ac-
cording to Boekhout et al. (2001). 
In the Southeast and South regions of Brazil, where 
consistent data are available, human cryptococcosis is 
caused predominantly by C. neoformans serotype A, 
VNI and is associated with AIDS (Casali et al. 2003, Ig-
reja et al. 2004). However, the few studies performed in 
the Northeast region suggest epidemiological differen-
ces, particularly the occurrence of meningitis by C. gat-
tii serotype B in native adults and children in this region 
(Lazera et al. 2005). Additionally, one study performed in 
the North region, in Belém do Pará, also describes cryp-
tococcosis in immunocompetent children (Corrêa et al. 
1999). To increase the understanding of cryptococcosis in 
the North region of Brazil, we performed a retrospective 
and prospective study of isolates obtained from patients 
with meningitis, identifying the species, serotypes and 
molecular types of Cryptococcus. Clinical and epidemi-
ological data were also analysed providing an epidemio-
logical view on cryptococcosis and its causative agents 
in the Eastern Amazon.
MATERIALS AND METHODS
Cryptococcus identification - From May 2003-April 
2007, isolates of Cryptococcus spp. isolated from pa-
tients admitted to the João Barros Barreto Hospital, a 
reference centre in the city of Belém, were identified by 
morphological and physiological tests, including phenol 
oxidase production on niger seed agar (NSA), cyclohe-
ximide sensitivity, assimilation of carbon and nitrogen 
sources (Vitek ICB, bioMerieux, Durham, USA) and 
growth in canavanine-glycine-bromothymol blue (CGB) 
media. Additionally, the Crypto-Chek Kit (Iatron Labo-
ratories, Tokyo, Japan) was used to discriminate between 
different serotypes of the same species.
Statistical analysis - The clinical and fungal data 
from the isolates were analysed with the chi-square test 
(Yates correction). All p-values less than 0.05 were con-
sidered significant.
Reference strains - The following set of standard 
laboratory strains, representing each molecular type, 
were used as controls in PCR-fingerprinting and URA5-
RFLP: WM 148 (serotype A, VNI), WM 626 (serotype 
A, VNII), WM 628 (serotype AD, VNIII), WM 629 (se-
rotype D, VNIV), WM 179 (serotype B, VGI), WM 178 
(serotype B, VGII), WM 161 (serotype B, VGIII) and 
WM 779 (serotype C, VGIV).  
DNA extraction - High molecular weight DNA was 
extracted according to Ferrer et al. (2001). Half an inocu-
lation loop of culture was frozen at -20°C for 1 h and then 
incubated at 65°C for 1 h in 0.5 mL of extraction buffer 
(50 mM Tris-HCl, 50 mM EDTA, 3% sodium dodecyl 
sulfate, 1% 2-mercaptoethanol). The lysate was extracted 
with phenol-chloroform-isoamyl alcohol (25:24:1, v:v:v). 
DNA was recovered by isopropanol precipitation, washed 
with 70% (v:v) ethanol and diluted in sterile water.
URA5-RFLP - PCR of the URA5 gene was conduct-
ed in a final volume of 50 μL. Each reaction contained 
50 ng of DNA, 1X PCR buffer (20 mM Tris-HCl, pH 
7.5, 100 mM NaCl, 0.1 mM EDTA, 2 mM DCT, 50% 
glycerol, 0.1% Tween-20 ), 0.2 mM of each dATP, 
dCTP, dGTP and dTTP (Roche Diagnostics GmbH), 
2 mM magnesium chloride, 2.5 U Taq DNA polymer-
ase (Bioline) and 25 ng of each primer URA5 (5’  AT-
GTCCTCCCAAGCCCTCGACTCCG 3’) and SJ01 (5’ 
TTAAGACCTCTGAACACCGTACTC 3’). PCR was 
performed for 35 cycles in a  Perkin-Elmer thermal cy-
cler (model 480) using the following parameters; 94°C 
for 5 min initial denaturation, 35 cycles denaturation at 
94°C for 45 s, 1 min annealing at 63°C and 2 min exten-
sion at 72°C, followed by a final extension cycle for 10 
min at 72°C. PCR products were double digested with 
Sau96I (10 U/µL) and HhaI (20 U/µl) for 3 h and the frag-
ments were separated on a 3% agarose gel stained with 
ethidium bromide. RFLP patterns were assigned visu-
ally by comparison with the patterns obtained from the 
reference strains described above.
PCR-fingerprinting - PCR-fingerprinting reactions 
were conducted in a volume of 50 µL containing 25 ng 
genomic DNA, 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 
1.5 mM MgCl, 0.2 mM each of dATP, dCTP, dGTP and 
dTTP (Roche Diagnostics GmbH, Mannheim, Germa-
ny), 3 mM magnesium acetate, 30 ng primer (5’ GAG-
GGTGGCGGTTCT 3’), and 2.5 U Amplitaq DNA poly-
merase (Applied Biosystems, Foster City, CA). PCR was 
performed for 35 cycles in a Perkin-Elmer thermal cy-
cler (model 480) with 20 s of denaturation at 94°C, 1 min 
annealing at 50°C and 20 s extension at 72°C, followed 
by a final extension cycle for 6 min at 72°C. Amplifica-
tion products were concentrated to approximately 15 µL 
and separated by electrophoresis on 1.4% agarose gels 
stained with ethidium bromide (Meyer et al. 2003). PCR-
fingerprinting profiles were visually compared to the 
reference strains to determine the molecular types. The 
genetic relationships of the isolates were analysed using 
the 1D gel analysis module (BioGalaxy [BioAware, Han-
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nut, Belgium]) in BioloMICS version 7.5.30 (BioAware). 
Similarity coefficients were calculated by using the Dice 
algorithm and cluster analyses were performed with the 
Unweighted Pair Group Method with Arithmetic mean.
Molecular determination of the mating type - The 
MAT α and MAT a pheromones were determined in all 
isolates by PCR according to Chaturvedi et al. (2000), us-
ing the α-mating type-specific primers 5’ - CTTCACT-
GCCATCTTCACCA-3’ and 5’ -GACACAAAGGGT-
CATGCCA-3’, and the a-mating type-specific primers 
5’ - CGC CTT CAC TGC TAC CTT CT-3’ and 5’ -AAC 
GCA AGA GTA AGT CGG GC-3’. C. gattii isolate mat-
ing types were determined using the primers MFA2U 
(5’ ACACCGCCTGTTACAATGGA 3’) and MFA2L (5’ 
CAGCGTTTGAAGATGGACTTT 3’), as described by 
Fraser et al. (2003).
RESULTS
A total of 56 cryptococcal isolates from 43 patients 
with meningitis were analysed. The majority of these 
isolates (54 of 56) were isolated from the cerebral spi-
nal fluid of patients, while only two were isolated from 
blood cultures. A single isolate was obtained from 31 
patients; two isolates were obtained from 11 patients and 
three from one patient. In this cohort, 26 (60.5%) pa-
tients were male and 17 (39.5%) female. Eight (18.6%) 
children (< 12 years old) were all HIV negative and the 
remaining 35 (81.4%) patients comprised 21 (60%) HIV-
negative and 14 (40%) HIV positive patients.
C. gattii was more frequently isolated from HIV-
negative patients (19/29; 65.5%) and C. neoformans was 
predominantly isolated from the HIV-positive patients 
(12/14, 85.7%; p < 0.005; OR = 11.4; IC95% 1.8-92.2). The 
remaining two HIV-positive patients had C. gattii-induced 
cryptococcosis (Table). The identification of the species 
of Cryptococcus by the CGB test demonstrated that of the 
56 isolates, 27 (48.2%) were C. neoformans, 20 (35.7%) 
were C. gattii and nine produced ambiguous results 
[16.1 % (Table)]. Based on the results of the serotyping 
analysis, 21 isolates were serotype B, 20 were serotype 
A and 15 were indeterminate (7 C. gattii and 8 C. neo-
formans). Five isolates obtained from two children from 
the Northeast nesoregion of Pará produced indeterminate 
results in both the serotyping and CGB tests. Three mo-
lecular types were identified by URA5-RFLP and PCR-
fingerprinting: VNI (28/56, 50%), VGII (25/56, 44.6%) 
and VGI [3/56, 5.4% (Table)]. The VNI genotype was iso-
lated from 12 of 14 HIV-positive adults, whereas the VGII 
genotype was isolated from 11 of 21 HIV-negative adults 
(p < 0.02, OR = 6.6 IC95% 0.98-56.0). All isolates were 
identified as MAT α using mating type-specific primers 
(Fraser et al. 2003, Holliday et al. 2003). The geographi-
cal origin of the 43 cases based on molecular type and 
mesoregion of the state of Pará is shown in Figure.
DISCUSSION
The North region of Brazil encompasses a large area 
of the Amazon rainforest and more studies on human 
cryptococcosis and the molecular profiles of the infect-
ing strain(s) need to be performed. A study on crypto-
coccosis in children in the state of Pará described 19 
cases, from which nine isolates were determined to be 
C. gattii (Corrêa et al. 1999). In the present study, the 
incidence of C. gattii-induced meningitis is similar to 
the previously described cases in the Northeast region 
(Lazera et al. 2005). However, it is distinct from the 
cases described in the South and Southeast regions of 
Brazil (Nishikawa et al. 2003).
In the state of Pará, C. gattii was the main causa-
tive agent of meningitis in the HIV-negative patients and 
occurred also in two HIV-positive patients. The high 
frequency of cryptococcal meningitis in HIV-negative 
children (8/43; 18.6%) observed from 2003-2007 sup-
ports  previous studies by Corrêa et al. (1999) and sug-
gests that cryptococcal infection occurs early in life in 
this region. Previous studies have demonstrated that 
infantile cryptococcosis accounts for a significant frac-
tion of cryptococcosis cases in the neighbouring state 
of Amazonas (33%, n = 75) (Santos 2000) and the Piauí 
and Maranhão, states of the Northeast region (21%, n = 
257) (Martins 2003). Since the present study is based on 
isolates obtained from patients representing only part of 
the cases, the real occurrence of this mycosis is largely 
underestimated.
We were unable to identify the Cryptococcus species 
in a significant number of isolates using the CGB test. 
Interfering factors, such as contamination or excessive 
inoculum, were excluded by re-plating on NSA medium 
and carefully repeating the test, which yielded the same 
results. Similarly, a significant number of isolates were 
untypable by serotyping. These results demonstrate the 
occurrence of atypical phenotypes among clinical iso-
lates in the state of Pará, which may cause difficulties 
in their species identification at the local public labora-
tories. Usually most Cryptococcus isolates are haploid, 
nevertheless some diploid or aneuploid isolates may lead 
to unstable phenotypes, which may be recombinants or 
hybrids (Kwon-Chung & Varma 2006). Further genetic 
studies are necessary to evaluate the atypical clinical 
isolates from Pará.
The molecular type VGII was found to be the main 
causative agent in cases of C. gattii-induced cryptococ-
cosis. These findings are in agreement with a recent 
Brazilian study demonstrating that the VGII genotype 
is the main cause of endemic cryptococcosis in immu-
nocompetent hosts in different states of the North and 
Northeast regions of Brazil (Trilles et al. 2008).
Most cases caused by the VGII and VNI types were 
from the metropolitan and Northeast mesoregions of 
Pará, both near the Hospital Universitário João de Bar-
ros Barreto. VGII and VNI types were also identified 
in more distant mesoregions of Pará such as Southeast, 
Southwest and Marajó. However, in the Lower Amazon 
mesoregion no case was identified, which may be due to 
the large distance that must be travelled (≥ 12 h by boat) 
to reach health services or the reference centre in the city 
of Belém. For the first time we demonstrate the occur-
rence and predominance of the molecular type VGII as 
an agent for cryptococcosis in normal individuals living 
in the state of Pará, including a significant number of 
paediatric cases. These paediatric cases came from dif-
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TABLE
Patient data, clinical samples and results of Cryptococcus isolates on CGB test, serotyping, molecular typing by PCR-finger-
printing using the primer M13 and RFLP URA5, according to mesoregions of the state of Pará, Brazil
Patient Gender Age HIV Sample LMM/WM number CGB Serotype Mol. Type Mesoregion - Belém
  1 male 45 pos CSF 1420 A/07207  UT VNI Metropolitan
    CSF 1420 B/07205 neg UT VNI 
  2 male 20 pos CSF 1421A/07206 neg UT VNI Metropolitan
    CSF 1421B/07207 neg UT VNI 
  3 male 43 pos CSF 1423/07209 neg A VNI Metropolitan
  4 female 31 pos CSF 1427/07213 neg A VNI Metropolitan
  5 male 27 pos CSF 1433/07221 neg A VNI Northeast
  6 male 28 pos CSF 1443/07233 neg A VNI Northeast
  7 male 58 pos CSF 1452/07242 neg A VNI Metropolitan
  8 male 29 pos CSF 1455/07245 neg A VNI Northeast
  9 male 33 pos CSF 1457/07247 neg A VNI Metropolitan
10 female 32 pos CSF 1471/07249 neg UT VGII Metropolitan
11 male 36 pos CSF 1483 A/07253 neg A VNI Northeast
    CSF 1483 B/07254 neg A VNI Northeast
12 female 42 pos CSF 1487/07259 neg A VNI Metropolitan
13 male 52 pos CSF 1463/ - pos UT VGII Metropolitan
14 male 34 pos CSF 1468/ - neg A VNI Southeast
15 female 38 neg CSF 1445/07235 neg A VNI Northeast
16 male 15 neg CSF 1422/07208 pos B VGII Northeast
17 female 19 neg CSF 1424/07210 neg A VNI Metropolitan
18 female 15 neg CSF 1425/07211 pos B VGII Southwest
19 female 28 neg CSF 1448/07238 neg A VNI Metropolitan
20 female 35 neg CSF 1450/07240 neg A VNI Metropolitan
21 female 21 neg CSF 1451/07241 pos B VGII Metropolitan
22 female 60 neg CSF 1426/07212 pos B VGII Metropolitan
23 female 33 neg CSF 1428/07214 pos B VGII Metropolitan
    blood 1429/07215 pos B VGII 
24 female 30 neg CSF 1432 A/07219 dub B VGII Southeast
    CSF 1432 B/07220 dub B VGII Southeast
25 male 65 neg CSF 1434 A/07222 neg UT VNI Metropolitan
    CSF 1434 B/07223 neg UT VNI 
26 male 42 neg CSF 1453/07243 pos B VGII Northeast
27 male 20 neg CSF 1454/07244 pos B VGII Metropolitan
28 male 32 neg CSF 1458/07248 pos B VGII Southeast
29 female 29 neg CSF 1481/07252 neg A VNI Marajó
30 female 24 neg CSF 1486 A/07257 pos B VGII Metropolitan
    CSF 1486 B/07258 pos B VGII 
31 female 42 neg blood 1489/07269 neg A VNI Northeast
    CSF 1492/07263 neg A VNI 
32 male 36 neg CSF 1490/07261 neg A VNI Metropolitan
33 male 17 neg CSF 1491/07262 neg A VNI Metropolitan
34 male 15 neg CSF 1485 A/07255 pos B VGII Metropolitan
    CSF 1485 B/07256 pos B VGII 
35 male 14 neg CSF 1459/ - pos B VGII Metropolitan
36 female 9 neg CSF 1430 A/07216 dub UT VGI Northeast
    CSF 1430 B/07217 dub UT VGI 
    CSF 1436/07225 dub UT VGI 
37 male 5 neg CSF 1431/07218 pos B VGII Northeast
38 male 11 neg CSF 1435/07224 pos B VGII Metropolitan
39 male 8 neg CSF 1441 A/07230 dub UT VGII Northeast
    CSF 1441 B/07231 dub UT VGII 
40 male 7 neg CSF 1444/07234 pos B VGII Northeast
41 Female 11 neg CSF 1449/07239 pos B VGII Southeast
42 male 6 neg CSF 1475 A/07250 dub UT VNI Northeast
    CSF 1475 B/07251 dub UT VNI 
43 male 8 neg CSF 1460/ - pos B VGII Metropolitan
CSF: cerebral spinal fluid; dub: dubious result; LMM: Pathogenic Fungi Collection, IPEC-Fiocruz; WM: Australian Medical Fungal 
Collection, Molecular Mycology Research Laboratory, Weastmead Hospital.  
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ferent mesoregions, suggesting that the environmental 
sources of VGII are widespread across the state. Addi-
tionally, one VGI case in a child from the Northeast me-
soregion indicates that this molecular type may be also 
present in the local environment.
The mesoregions of Pará, with the exception of the 
metropolitan mesoregion, are mainly occupied by small 
communities and villages in the Amazon rainforest and 
share areas for cattle pastures and wood exploitation. 
The metropolitan mesoregion contains the areas of ur-
banization surrounding the city and harbour of Belém. 
At this port of the Amazon estuary, an extensive trade of 
wood and wood by-products, both for local use and for 
export, takes place. In Brazil, C. gattii and C. neofor-
mans have been described in the decaying heartwood of 
a number of tree species, a possible primary ecological 
niche for both pathogens (Lazera et al. 2000). C. gat-
tii was isolated from wood decay in a native jungle tree 
(Guettarda acreana) in Maracá, a river island without 
human activity in the Occidental Amazon rainforest, 
North Brazil (Fortes et al. 2001). This finding provides 
evidence that wild tropical forests may harbour C. gattii. 
The C. gattii isolated from the Guettarda tree was fur-
ther identified as genotype AFLP6 (Trilles et al. 2003), 
which corresponds to the molecular type VGII. 
C. gattii AFLP6/VGII seems to be well-adapted to 
the semiarid region in Northeastern Brazil, where it was 
isolated from the spleen of one armadillo, from wood 
decay in different trees and from human clinical speci-
mens (Trilles et al. 2003). The genotype VGII is also the 
causative agent of the largest known outbreak infecting 
humans and animals and the first reported in a temper-
ate area, Vancouver Island, Canada (Kidd et al. 2004). 
Considering the adaptive potential, expansive behaviour 
and pathogenicity of this molecular type, it is necessary 
to place accessible medical units in areas far from the 
city of Belém. These units will be able to provide spe-
cific medical information and laboratories for the early 
diagnosis, fungal isolation, identification and storage of 
the isolates. Additionally, these units can function as a 
registration system for the active surveillance of crypto-
coccosis in the state of Pará, Brazil. 
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